Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.

Vermersch, P; Czlonkowska, A; Grimaldi, Lm; Confavreux, C; Comi, Giancarlo; Kappos, L; Olsson, Tp; Benamor, M; Bauer, D; Truffinet, P; Church, M; Miller, Ae; Wolinsky, Js; Freedman, Ms; O'Connor, P; for the TENERE Trial, Group